Up to 15 % of free-ranging mule deer in northeastern Colorado and southeastern Wyoming, USA, are afflicted with a prion disease, or transmissible spongiform encephalopathy (TSE), known as chronic wasting disease (CWD). CWD is similar to a subset of TSEs including scrapie and variant Creutzfeldt-Jakob disease in which the abnormal prion protein isoform, PrP 
Introduction
Chronic wasting disease (CWD) is the only prion disease, or transmissible spongiform encephalopathy (TSE), known to affect free-ranging wildlife (Spraker et al., 1997 ; Williams & Young, 1992 . In endemic areas of Colorado and sheep (van Keulen et al., 1996) and variant Creutzfeldt-Jakob disease (vCJD) of humans (Hill et al., 1999) .
Lymphoid tropism differs among the TSEs -these differences possibly reflect variants of prion disease pathogenesis. For example, in bovine spongiform encephalopathy (BSE) no detectable PrP res or infectivity is detectable in spleen (Somerville et al., 1997) or lymph nodes (Wells et al., 1998) , unlike CWD, sheep scrapie and vCJD (Hill et al., 1999 ; Spraker et al., 2002 ; van Keulen et al., 1996) . However, experimental inoculation of BSE into sheep does result in detectable lymphoid PrP res (Foster et al., 2001 ; Jeffrey et al., 2001) . Moreover, lymphotropism appears to be determined not only by host species, but also by prion strain : for example, humans with vCJD have lymphoid PrP res accumulation or infectivity (Bruce et al., 2001 ; Hill et al., 1999 ; Hilton et al., 1998) whereas humans with sporadic or iatrogenic CJD do not have lymphoid PrP res accumulation (Hill et al., 1999) .
Naturally infected deer with advanced CWD have CWD PrP res (PrP CWD ) disseminated throughout lymph nodes, spleen, tonsils and Peyer's patches. In tonsils, PrP CWD accumulation is restricted primarily to germinal centres and is present in 50 % of secondary follicles (Spraker et al., 2002) . In fawns orally inoculated with CWD brain homogenate, PrP CWD was detected in alimentary-associated lymphoid tissues as early as 6 weeks post-inoculation (p.i.). In these early stages of infection, PrP CWD was limited to 30 % of secondary follicles, which were typically clustered, suggesting a common conduit or seeding site into the draining lymph node (Sigurdson et al., 1999) .
The mechanisms of lymphoid tissue PrP CWD accumulation remain uncertain, although studies in natural and experimental scrapie (Andreoletti et al., 2000 ; Brown et al., 2000 ; Jeffrey et al., 2000 ; Kitamoto et al., 1991 ; McBride et al., 1992 ; Montrasio et al., 2000) , CJD in mice (Manuelidis et al., 2000) and vCJD in humans (Hill et al., 1999) provide evidence for PrP res association with follicular dendritic cells (FDC) and\or tingible body (TB) macrophages. With the abundant PrP CWD in lymphoid tissues of deer, it seems possible that PrP CWDcontaining lymphoid cells could traffic into the blood. Several studies have established that PrP res strongly correlates with infectivity (Bolton et al., 1991 ; McKinley et al., 1983 ; Race et al., 1998) . Therefore, with the hope of gaining insight into potential trafficking, conversion or capture sites of PrP CWD , we studied the spatial relationship of the protease-resistant prion protein to lymphoid cell phenotypes in the tonsils and lymph nodes of mule deer naturally or experimentally infected with CWD by triple-immunofluorescent labelling and laser scanning confocal microscopy. We found PrP CWD almost exclusively in association with cell membrane surfaces. In addition, smaller deposits of PrP CWD were detected intracytoplasmically in CD68 + macrophages or dendritic cells within germinal centres and much less commonly within the paracortical zone of lymph nodes. These results are reminiscent of those of Jeffrey et al. (2000) regarding PrP Sc and suggest to us that either : (a) PrP CWD conversion occurs at the surface rather than within FDCs or (b) PrP CWD formation occurs at distant sites and is concentrated at FDC surfaces.
Methods
CWD-infected deer and tissue collection. Tonsils or retropharyngeal lymph nodes from CWD-positive deer were acquired from three groups of captive mule deer (Odocoileus hemionus) in various stages of infection : (1) tonsils from six deer with naturally occurring, clinical CWD, (2) retropharyngeal lymph nodes from two fawns orally inoculated with a CWD brain homogenate and euthanized at 42 and 78 days p.i., and (3) tonsil biopsies from three naturally infected, asymptomatic deer from a captive herd with endemic CWD. The asymptomatic deer eventually developed clinical signs of CWD and were euthanized (CWD confirmed with brain immunohistochemical staining (IHC) for PrP CWD ). Tonsils were fixed in 10 % neutral buffered formalin for 1-3 days then immersed in 88 % formic acid for 1 h and embedded in paraffin.
The clinically affected CWD-positive deer were diagnosed by : (1) histological lesions of CWD in the medulla oblongata including perikaryonic neuronal vacuoles, spongiform degeneration of the neuropil and astrocytosis, and (2) abundant PrP CWD staining in the medulla oblongata by IHC (methods described in Sigurdson et al., 2001) . Deer were confirmed as CWD-negative by the absence of histological brain lesions and negative staining for PrP CWD in brain and tonsil.
Negative control deer and tissues. Tonsils from CWD-negative mule deer were acquired from two sources : (1) adult deer from the CWD non-endemic area (non-endemic area established by methods in and (2) two mule deer fawns inoculated with CWD-negative brain homogenate from a previous study (Sigurdson et al., 1999) . Tissues were similarly fixed and processed.
Phenotype antibodies. Several antibodies which recognize lymphoid epitopes on deer lymphoid cells were used. These included antibodies which recognize : (1) lambda light chain (DAKO), present in antigen-antibody complexes on FDC membrane surfaces and on B cells, (2) cc21 (CD21 or complement receptor type 2) (antibody generously donated by Dr Chris Howard), a receptor that traps immune complexes on FDC surfaces also expressed by B cells (Zabel & Weis, 2001) , (3) CD68 (Serotec), an intracytoplasmic, lysosome-associated epitope within macrophages and human DC (Betjes et al., 1991) , (4) ferritin (DAKO), a large protein surrounding a core of ferric oxide which functions to store and detoxify iron (Morikawa et al., 1995) in macrophages (Kindblom et al., 1982) , (5) heat shock protein 70 (HSP70) (DAKO) in macrophages (Bachelet et al., 1998) , (6) vimentin (DAKO), an intermediate filament in TB macrophages (Giorno, 1985) and FDC (Tsunoda et al., 1990) , (7) anti-FDC (DAKO), which targets a 120 kDa epitope in FDC of humans (Raymond et al., 1997) and has been shown to cross-react with sheep FDC (Lezmi et al., 2001) , (8) S100 (DAKO), a calcium-binding protein present in FDC and\or TB macrophages, depending on the species (Carbone et al., 1988) , and (9) CD3 (DAKO), an intracytoplasmic domain of the CD3 epsilon chain of T cells.
Immunofluorescent staining. Tissue sections (6 µm) were mounted onto positively charged glass slides, deparaffinized, hydrated, autoclaved in a buffer solution (DAKO Target Antigen Retrieval) for 12 min at 121 mC, and cooled for 5 min. Sections were rinsed in PBS and immersed in 3 % H # O # for 15 min to quench endogenous peroxidase. Sections were then briefly rinsed in PBS and incubated in TNB blocking solution (NEN Sciences) for 30 min followed by exposure to 1-2 lymphoid phenotype antibodies and anti-PrP antibody 6H4 (monoclonal, IgG, 1 : 200 dilution) or R522 (polyclonal, 1 : 1500 dilution) for 30 min at PrP CWD lymphoid cell targets PrP CWD lymphoid cell targets room temperature. mAb 6H4 recognizes a conserved sequence of the prion protein, corresponding to the human amino acid sequence 144-152 (Korth et al., 1997) . R522 recognizes ovine PrP 94-105 (Garssen et al., 2000 ; van Keulen et al., 1995) . Antibodies were diluted in a protein block containing goat serum (Biogenex). Since HSP epitopes appear to be destroyed by autoclaving, slides stained for HSP and PrP were initially labelled for HSP, followed by autoclaving and labelling for PrP CWD . In general, phenotype antibodies were labelled with FITC or Alexa 488 (Molecular Probes) and PrP labelled with CY3. In sections labelled for HSP or CD68, PrP CWD was labelled with FITC. Tyramide amplification (NEN Sciences) was used to enhance stain signal on R522, ferritin and HSP labels. Slides were coverslipped using anti-fade mounting media (Molecular Probes). CWDnegative deer tissues were incubated with an anti-PrP antibody and an isotype-and concentration-matched rabbit or mouse antibody to control for the phenotype antibody.
Confocal microscopy. To co-localize the cell phenotype marker and PrP CWD , triple immunofluorescently labelled sections were examined using an Olympus FLUOVIEW laser scanning confocal microscope equipped with 12-bit resolution which allows for data acquisition from three fluorescent channels using three lasers, Argon 488 nm, HeNe 543 nm and HeNe 622 nm ; these emit in the green, red and far-red spectra, respectively. Secondary follicles were selected from each tonsil section and sequentially scanned using the three lasers.
Quantification of co-localization of PrP
CWD and phenotype marker. Images from each deer were analysed using Metamorph software (Universal Imaging Corp., West Chester, PA) applying the colour thresholding tool to differentiate the positively stained cells from the unstained cells. Percent co-localization of PrP CWD with the phenotype marker stain was measured using the co-localization tool and recorded on a Microsoft Excel spreadsheet. For each tissue section, two follicles (900i magnification) were analysed for PrP CWD and phenotype marker co-labelling, and the results were averaged. Data were analysed using Student's t-test. Significance was defined at P 0n05.
Dual immunocytochemical (ICC) staining.
To determine whether PrP CWD could be associated with individual cells from a CWDinfected lymph node, we collected the retropharyngeal lymph node into cold cell culture medium immediately after euthanasia. Single cell suspensions were prepared by mincing and incubating 2 mm$ sections in serum-enriched medium containing collagenase, dispase and DNase at 37 mC with agitation to digest the stroma and release the cells. The cells were pelleted by centrifugation, washed in PBS, and then cytocentrifuged onto positively charged glass slides. Cells were fixed in 10 % buffered formalin for 15 min and pretreated by hydrated autoclaving if necessary immediately prior to immunostaining.
The ICC protocol employed an automated immunostainer (Ventana Medical Systems) and was separated into two stages. First, the cells were labelled with a phenotype marker using the appropriate phenotype antibody, a biotinylated secondary antibody, a horseradish peroxidasestreptavidin conjugate and a diaminobenzadine chromagen. Second, hydrated autoclaving was performed on cell preparations not previously autoclaved and the cells were labelled for PrP CWD using PrP mAb F99\97.6.1 (generously provided by Dr Katherine O'Rourke) (Spraker et al., 2002) , a biotinylated secondary antibody, an alkaline phosphatase-streptavidin conjugate, a substrate chromagen (fast red A), and a haematoxylin and bluing counterstain (Ventana Medical Systems). mAb F99\97.6.1 reacts with a conserved epitope (residues QYQRES) on the prion protein of mule deer, Rocky Mountain elk, domestic sheep and cattle (Spraker et al., 2002 ). An isotype-matched, irrelevant antibody was substituted in the ICC protocol as a negative control for the phenotype marker. The anti-PrP antibody was applied to both CWD-negative and -positive deer cell preparations.
IHC was performed on lymphoid tissue as described for the ICC utilizing anti-PrP mAbs F89\160.1.5 and F99\97.6.1. mAb F89\160.1.5 recognizes a conserved epitope of the prion protein of mule deer, elk, sheep and cattle (residues IHFG) (O'Rourke et al., 1998) .
Results
Lymphoid cells in the germinal centres include FDC, TB macrophages, T and B lymphocytes, and germinal centre dendritic cells. Germinal centre dendritic cells, a dendritic cell subset in the tonsil that presents antigen to germinal centre B cells, have been described in humans (Grouard et al., 1996 ; Summers et al., 2001) but not in ruminants.
Because PrP CWD deposits accumulate within germinal centres of primary and secondary lymphoid follicles, we focused on phenotype marker antibodies which would target FDC, B and T lymphocytes, and TB macrophages. To ensure that the human antigen-derived phenotype antibodies recognized the appropriate target epitope, we compared the cell staining patterns of our phenotype antibodies in human and deer tonsil sections and determined that the antibodies identified lymphoid cells with similar morphology and anatomical distribution.
PrP CWD in lymphoid germinal centres
In tonsils of all CWD-infected deer examined by IHC, PrP CWD was concentrated primarily in lymphoid follicle germinal centres (Fig. 1) . Tonsils from deer with clinical CWD or tonsil biopsies from preclinical, CWD-infected deer had a CWD is on the cell surface of FDC. Lymphoid follicle within a CWD-positive deer tonsil stained using two triplelabelling protocols. PrP CWD (panels a, e, red, antibody 6H4) co-localizes with cell membrane markers for cc21 and immunoglobulin (Ig) (panels c, g, blue) visible as pink in the merged image (panels d, h). PrP CWD (red) does not co-localize with intracellular FDC labels, S100 and FDC (green), as apparent by the lack of yellow in merged images (panels d, h). Bar, 50 µm. high frequency (" 80-100 %) of PrP CWD -positive follicles. By contrast, in fawns examined 7 to 11 weeks after oral CWD exposure, 30 % of retropharyngeal lymph node follicles contained detectable PrP CWD . Although PrP CWD was found primarily within the germinal centres, it was also detected occasionally in cells within perifollicular areas (Fig. 1) .
PrP

CWD accumulates on FDC membranes
To study the association of PrP CWD with germinal centre cells, we co-labelled tonsil sections for PrP CWD , FDC and other lymphoid cell phenotypes. Three cytoplasmic phenotype markers were used to identify FDC : S100, vimentin and anti-CGCA PrP CWD lymphoid cell targets PrP CWD lymphoid cell targets FDC (see Methods for details on antibodies). To investigate whether PrP CWD accumulated on the cell membrane or cytoplasmically with respect to FDC, we also triple-labelled tonsil sections with antibodies targeting two membrane-bound epitopes associated with FDC and B cell membranes : lambda light chain and cc21 (CD21 or complement receptor type 2). Using confocal microscopy, we found that co-localization of PrP CWD with the FDC intracellular phenotype markers was rare, though PrP CWD appeared in close association with FDC (Fig. 2) .
Although the lack of co-localization of PrP CWD with the FDC cytoplasmic markers (S100 and anti-FDC) was visually apparent as assessed by the lack of yellow stain, we quantified and compared the co-localization of PrP CWD with intracytoplasmic and membrane markers using Metamorph software. PrP CWD co-localization with the extracellular markers was approximately four times higher than with intracellular FDC markers (P 0n05 by Student's t-test ; Fig. 5 ). We concluded that PrP CWD accumulated primarily on membranes associated with FDC and B lymphocytes. To verify our results, we analysed tonsil sections labelled with the intracytoplasmic marker vimentin at a higher magnification (900i with zoom) and created a stack of individual optical sections " 0n3 microns apart through the tissue. At high magnification, PrP CWD co-localized strongly with lambda light chain and poorly with vimentin ( Fig. 3a-c) ; this labelling pattern was consistent throughout the thickness of the tissue section (Fig. 3d-h) .
We then characterized PrP CWD in relation to individual cells at high magnification. Using the FDC intracytoplasmic label (S100) and a nuclear stain, we found that PrP CWD was present on the plasma membrane surface and on the fine processes of the FDC (Fig. 4a) . Perpendicular sections through a cell labelled with S100 and cc21 antibodies indicated that even in three-dimensional views PrP CWD co-localized only with the plasma membrane marker and did not appear to be intracytoplasmic (Fig. 4b) .
To determine whether T cells may harbour PrP CWD , we colabelled tonsil sections for PrP CWD and T cell receptor CD3. We found that relatively low numbers of T cells were present and no consistent intimate association was evident between these CD3 + cells and PrP CWD (data not shown).
PrP
CWD in the cytoplasm of TB macrophages
Perifollicular cells containing PrP CWD were seen in chromagen-based IHC staining of lymph nodes (Fig. 6a, b phenotype these cells, we triple-labelled a tonsil section using antibodies against PrP CWD , nuclei and CD68, which labels a lysosomal epitope of macrophages and human dendritic cells, and found that PrP CWD was associated with CD68 + macrophages or dendritic cells (Fig. 6c, d) .
We investigated whether TB macrophages were involved in PrP CWD accumulation based on earlier experiments in which PrP CWD staining was visualized in cells morphologically characteristic of TB macrophages (see Fig. 9 ). To determine whether TB macrophages in germinal centres accumulated PrP CWD , we used three intracellular antibody markers for TB macrophages : CD68, HSP70 and ferritin.
In HSP70-labelled sections examined at high magnification, we found that PrP CWD was closely associated with HSP70 (Fig.  7a, b) . Serial optical sections through a single cell consistently demonstrated PrP CWD adjacent to the intracellular TB macrophage marker (HSP70), indicating that PrP CWD was intracellular ( Fig. 7c-f) . Similar results were seen with the ferritin label (data not shown). At high magnification, PrP CWD occasionally co-localized with the macrophage phenotype marker CD68 (Fig. 8) . To conclude, two populations of macrophages contained PrP CWD : (1) TB macrophages within germinal centres and (2) isolated macrophages or possibly dendritic cells in the perifollicular area.
PrP
CWD in separated lymphoid cells
In a further attempt to determine whether PrP CWD was membrane associated and affiliated with FDC, we examined lymphoid cells enzymatically digested from a CWD-infected retropharyngeal lymph node. Using cytospin preparations of lymphoid cells stained for S100 and PrP CWD , we found that many PrP CWD -bearing cells labelled for S100, identifying them as FDC (Fig. 9) . In addition, however, some PrP CWD -containing cells also stained positively for ferritin, a trait most compatible with macrophages. Occasionally PrP CWD -positive cells also co-labelled for lambda light chain or vimentin, traits compatible with FDC, TB macrophages or B cells. These experiments demonstrated that : (1) PrP CWD was cell associated, and (2) PrP CWD -harbouring cells were positive for either S100, ferritin, vimentin or lambda light chain, confirming that at least FDC and macrophages were accumulating PrP CWD .
PrP
CWD lymphoid cell association in preclinical CWD-infected deer
To determine whether the lymphoid cell association of PrP CWD changed through the course of infection, we compared PrP CWD lymphoid target cells from deer in early, asymptomatic stages of infection to deer with clinical signs of advanced CWD. The PrP CWD distribution in tonsil biopsies from asymptomatic, naturally exposed deer was similar to that in the tonsils from clinically affected deer. In contrast, in fawns sacrificed 6-11 weeks post-oral inoculation, PrP CWD was distributed primarily on FDC and B cell membrane surfaces with less involvement of TB macrophages. One fawn (6 weeks p.i.) had no apparent PrP CWD in TB macrophages ; PrP CWD was primarily associated with cell membranes. In a second fawn (11 weeks p.i.) PrP CWD was detected in both the cell membrane (FDC\B cells) and intracellular (TB macrophages) patterns. These studies suggested that PrP CWD accumulated first in association with FDC vs macrophages and that no additional cell associations were apparent in early pre-clinical stages of infection.
Discussion
A prominent feature of CWD in mule deer is the abundant PrP CWD accumulation in lymphoid germinal centres, similar to that in variant CJD in humans (Hill et al., 1999 ; Hilton et al., 1998) and scrapie in sheep (Andreoletti et al., 2000 ; Heggebø et al., 2000 ; van Keulen et al., 1996) . PrP Sc \PrP CWD or infectivity is initially detectable in alimentary-associated lymphoid tissue within weeks following oral exposure and months before detection in the brain (Andreoletti et al., 2000 ; Hadlow et al., 1982 ; Kimberlin & Walker, 1989 ;  PrP CWD lymphoid cell targets PrP CWD lymphoid cell targets Sigurdson et al., 1999 ; van Keulen et al., 2000 ; . While PrP CWD accumulates in lymph nodes in these early stages of infection, the role of specific immune system cells in prion replication and trafficking to the central nervous system (CNS) remains unclear.
Our observations indicate that PrP CWD accumulates in close association with FDC (Fig. 10) . Due to the close contact of FDC processes with numerous B cells (emperiopolesis), it is possible that PrP CWD is also on B cell membranes, or is in the extracellular space between FDC and B cells. This finding is consistent with two recent studies in the mouse TSE models demonstrating FDC membrane-associated PrP Sc : Jeffrey et al. (2000) used immunogold labelling to elegantly demonstrate ME7 PrP Sc on the plasmalemma of splenic FDC. Secondly, Manuelidis et al. (2000) used confocal microscopy to localize strain FU CJD PrP res on FDC membranes. Interestingly, the localization of infectious agent to FDC is not unique to TSEs. Other infectious agents, especially viruses, have been described on FDC surfaces, including bovine viral diarrhoea (Fray et al., 2000) and human immunodeficiency viruses (Fujiwara et al., 1999 ; Joling et al., 1993 ; Schmitz et al., 1994) .
Although FDC have been associated with PrP Sc (Brown et al., 1999 ; Hill et al., 1999 ; Kitamoto et al., 1991 ; McBride et al., 1992 ; Ritchie et al., 1999) , whether FDC replicate or merely harbour prions remains controversial. For example, Montrasio et al. (2000) demonstrated that inhibition of FDC development virtually eliminated splenic PrP Sc . Mabbott et al. (2000) found similar results if mice had FDC deleted prior to scrapie challenge ; however, when FDC were deleted after challenge, mice developed high levels of splenic infectivity. Moreover, in experiments using chimeric mice in which PrP C expression between FDC and other lymphoid cells was mismatched, Brown et al. (1999) found that only those mice expressing PrP C in FDC were susceptible to scrapie, strongly suggesting prion propagation by FDC. In contrast, Manuelidis et al. (2000) concluded that limiting intraperitoneal doses of CJD into FDCdeficient mice resulted in only a slightly prolonged incubation period over wild-type controls, suggesting FDC do not play a key role in this model. In our confocal microscopy study of PrP CWD in deer tonsils, serial images through FDC failed to reveal intracytoplasmic PrP CWD , which might indicate that FDC do not uptake or convert appreciable PrP CWD in the cytoplasmic compartment. This finding suggests that FDC may convert PrP C at the cell membrane or that intracellular conversion may be followed by rapid PrP CWD exocytosis. Another possibility would be that the FDC could act as scaffold for passive capture of PrP CWD on the cell membrane, potentially in association with complement or Fc-γ receptors. The association of PrP CWD on cell membranes is consistent with recent evidence for complement involvement in prion pathogenesis, shown by Klein et al. (2001) and Mabbott et al. (2001) .
Unlike the membrane-associated PrP CWD of FDC, intracytoplasmic large, dense aggregates of PrP CWD were detected in TB macrophages. This finding is reminiscent of studies showing PrP Sc deposits associated with CD68 + cells (Andreoletti et al., 2000) or cells morphologically consistent with TB macrophages in naturally infected scrapie sheep (van Keulen et al., 1996) . Moreover, Jeffrey et al. (2000) described PrP Sc in lysosomes of TB macrophages, consistent with immunogold electron microscopy studies localizing PrP Sc in lysosomes of neurons (Laszlo et al., 1992) .
There are several potential roles for the TB macrophages in prion pathogenesis. It is possible that CD68 + dendritic cells or macrophages transport PrP CWD into the germinal centre and expose the FDC, T and B cells to PrP CWD . CD68 + cells harbouring PrP CWD or PrP Sc (Andreoletti et al., 2000) have been localized adjacent to germinal centres. However, TB macrophages are in close contact with FDC and are known to phagocytose immune complex-coated bodies (iccosomes) on FDC membranes (Szakal et al., 1988) . TB macrophages may phagocytose PrP CWD -retaining FDC cell fragments (Heinen et al., 1993) and extracellular PrP CWD amyloid, and may or may not replicate PrP CWD , as suggested by Jeffrey et al. (2000) . In addition, TB macrophages phagocytose apoptotic B cells, which also could serve as a potential source of PrP CWD exposure. Therefore, PrP CWD accumulation in TB macrophages may be a secondary event which follows FDC PrP CWD accumulation.
While CD3 + T cells were present in germinal centres, a consistent association between these cells and PrP CWD deposits was not detected, although this association was difficult to assess due to the low number of T cells. Studies with scrapie in transgenic and immunodeficient mice suggest that T cells do not affect disease susceptibility or splenic infectivity (Klein et al., 1997 (Klein et al., , 1998 . Nevertheless, the involvement of T cells in CWD pathogenesis remains an open question.
Although PrP CWD was primarily localized to germinal centres, PrP CWD was not restricted to follicles in all lymphoid tissue studied. Scattered cells in the paracortical zone and medullary cords of lymph nodes occasionally contained PrP CWD . These cells invariably labelled for CD68, indicating that they were either macrophages or dendritic cells. Surprisingly few differences in the lymphoid cells associated with PrP CWD were seen in fawns weeks after oral exposure to CWD when compared to naturally infected deer with advanced CWD. One fawn at 6 weeks p.i. had PrP CWD extracellularly with no detectable involvement of TB macrophages. We speculate that the TB macrophages may be phagocytosing extracellular PrP CWD iccosomes and that there is a short lag before TB macrophages contain PrP CWD . This scenario could explain why 1 fawn (6 weeks p.i.) had no apparent PrP CWD in TB macrophages versus a second fawn (11 weeks p.i.). In scrapie-inoculated mice at 70 and 170 days p.i., the cell labelling of PrP Sc was similar at both time-points (Jeffrey et al., 2000) . In contrast, in sheep naturally infected with scrapie, PrP Sc was apparent in CD68 + cells prior to detection in FDC (Andreoletti et al., 2000) .
The close association of PrP CWD with the membrane surfaces of FDC and B cells and the presence of intracytoplasmic PrP CWD in TB macrophages raises questions as to the contribution of each of these cell types to PrP CWD replication and trafficking. Our findings in naturally infected deer add to those in CJD-and scrapie-infected mice, and may lend insight into the lymphoid cell targets in vCJD. Understanding peripheral lymphoid reservoirs may be central to deciphering prion trafficking routes from mucosal surfaces and could be critical to diagnostic and intervention measures during the preclinical stages of prion infections.
